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Available online xxxxBackground: Objective assessment of maximal aerobic capacity using peak oxygen consumption (peak VO2) can
be helpful in themanagement of patientswith asymptomatic aortic stenosis (AS). The relationship between peak
VO2 and AS severity criteria derived from rest and supine exercise echocardiography (SEE) has never been
explored.
Objectives:We aimed to determine whether low peak VO2 (b85% of predicted value) is associated with severity
parameters in SEE, and poor clinical outcome.
Methods: Fifty one asymptomatic patients (mean age of 54 ± 21 years) with moderate to severe aortic stenosis
(Vmax N 3 m/s) and left ventricle ejection fraction N 50% prospectively underwent resting and SEE and
cardiopulmonary exercise testing (CPX).
Results: Peak VO2was lower than expected (21.9 ± 7.4 mL/kg/min), i.e. b85% of predicted value in 57% patients,
secondary to cardiac limitation in most of them (69%). In multiple regression analysis, age, BMI and female
gender were the only independent determinants of peak VO2. Interestingly no parameter derived from SEE
was associated with peak VO2. After 21 ± 7 month follow-up, no patient died, 20 underwent cardiac surgery.
Peak VO2 b 85% of predicted value was associated with lower event free survival compared to normal peak
VO2 (57% ± 11% vs 93 ± 6%, p = 0.036) whereas no exercise echocardiographic parameter could predict such
events. Peak VO2 ≥ 85% had a negative predictive value of 97%.
Conclusion: CPX detects a high proportion of false asymptomatic AS patients with poorer outcome that cannot be
predicted by SEE markers of AS severity. Assessment of aerobic capacity should be part of current approach
within a “watchful waiting” strategy.






Severe aortic stenosis (AS) is the most common indication for valve
replacement in United States and Europe with aging of population.
Current guidelines recommend aortic valve replacement for severe AS
in case of symptoms or when left ventricle ejection fraction (LVEF) isIndex; CPX, Cardiopulmonary
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016), http://dx.doi.org/10.10b50% [1] as surgery improves symptoms, LV function and survival.
Concerns remain regarding the best therapeutic option for asymptom-
atic patients with moderate to severe AS and preserved LVEF. On the
one hand, sudden cardiac death not preceded by symptoms occurs in
1% of these patients per year, and early surgery has recently been sug-
gested in centers with very low operative risk [2–6]. On the other
hand, isolated aortic valve replacement carries on operative mortality
of 2.8 to 3.7% in large recent registries [1,7], and referring too early
asymptomatic patients to premature surgery exposes them to the
potential risk for long-term valve prosthesis complications.
As elective surgery cannot be recommended in every patient
with asymptomatic severe aortic stenosis, reliable risk estimation, ap-
propriate AVR indication and timing are important clinical challenges.
In this approach, the accurate determination of symptoms is crucialsting is a better outcome predictor than exercise echocardiography in
16/j.ijcard.2016.10.070
2 O. Domanski et al. / International Journal of Cardiology xxx (2016) xxx–xxxand currently based on systematic exercise testing to unmask symp-
toms or abnormal blood pressure response. Indeed many patients may
unconsciously reduce their level of physical activity [1].
In the past few years, both supine exercise echocardiography and
cardiopulmonary exercise testing (CPX) have been proposed for risk
stratiﬁcation in asymptomatic AS. Decrease of LVEF (N3%), signiﬁcant
elevation in transaortic mean gradient (N18 mm Hg) or pulmonary
hypertension (PHT) (N60 mmHg) during supine exercise echocardiog-
raphy has been associated with cardiac events, i.e. aortic valve replace-
ment or cardiovascular death [8–11]. Peak oxygen consumption (peak
VO2) measured during CPX was found to objectively assess functional
capacity in this population and may predict survival in retrospective
studies [12,13].
No study has prospectively explored the additive prognosis value
of CPX on top of current prognosis markers yet. We hypothesized
that alteration of aerobic capacity (deﬁned as peak VO2 b 85% of
predicted value) in asymptomatic AS could be associated with severity




Consecutive asymptomatic patients with moderate to severe AS (peak aortic jet
velocity ≥ 3 m/s and preserved LVEF N 50%) referred to our center from December 2012
to June 2015 for risk stratiﬁcation underwent resting and supine exercise echocardiogra-
phy, CPX and biology. The referring cardiologist recorded medical history and carefully
checked the absence of any symptoms. Exclusion criteria were: (i) symptoms including
dyspnea, angina or syncope, (ii) more than mild aortic or mitral regurgitation at resting
echocardiography, (iii) history of aortic valve surgery, (iv) atrial ﬁbrillation,
(v) LVEF b 50%, and (vi) inability to perform supine exercise echocardiography or CPX.
All patients gave informed consent for these explorations during the ﬁrst medical visit
to our hospital in accordance with local ethical committee.
2.2. Resting and supine exercise echocardiography
Echocardiographic examination was performed using a Vivid E9 Ultrasound system
(General Electrics Healthcare). All Doppler echocardiographic data were stored on a ded-
icated workstation (Echo-PAC software, General Electrics Healthcare) for subsequent
ofﬂine analysis.
Before exercise test, all patients underwent a comprehensive resting examination
that included M-mode, two-dimensional echocardiography, pulsed-wave and
continuous-wave Doppler measurements, according to guidelines [1,14–16], by an
experienced echocardiographist. The assessment of systolic function was made by
Simpson's biplane method at rest and peak exercise. Multiple transducer positions
were used to record peak aortic jet velocities, and aortic valve area was calculated
with the continuity equation [17], after careful measurement of left ventricular out-
ﬂow tract (LVOT) diameter. Standard 2D greyscale images focused on the LV were
acquired in 4-chamber, 2-chamber and long-axis views at high frame rates (between
50 and 80/s) in order to obtain LV global longitudinal strain by 2D speckle tracking,
using ECHO-PAC dedicated software (General Electrics Healthcare). If necessary the
region of interest automatically tracked by the device was manually corrected.
Pulmonary hypertension and valvulo-arterial impedance (Zva) were calculated as
previously described [10,18].
A symptom-limitedmaximal bicycle exercise test was performed the same day in the
semi-supine position (eBike EL, General Electrics Healthcare). All exercise 2D and Doppler
datawere obtained at 25Wandat peak exercise as previouslydescribed byour group [19].
No medication was stopped before the examination. After an initial workload of 25 W
maintained for 2min, itwas increased every 2min by 20W. A 12-lead ECGwasmonitored
continuously and blood pressure was measured at rest and every 2 min during exercise.
Aortic transvalvular maximal velocity was recorded in apical 5-chamber view during ex-
ercise. Abnormal test was deﬁned as: (i) occurrence of angina, dizziness or syncope, (ii)
complex ventricular arrhythmia, or (iii) fall of systolic blood pressure during
exercise ≥ 20 mm Hg.
Exercise PHT N 60 mm Hg, increase of mean transaortic gradient N 18 mm Hg and
decrease of LVEF N 3% were considered as exercise echocardiographic parameters of
bad prognosis as previously described [9–11].
2.3. Cardiopulmonary exercise testing (CPX)
All patients underwent a treadmill CPX on an Ergoline 800® bicycle (Sensormedics,
Yorba Linda, United States) with respiratory gas-exchange analysis, using a modiﬁed
Bruce protocol (progressive increase in workload of 10–15 W/min) as already described
by our group [20]. Each CPX was performed within the month following
echocardiographic examination. Patients' medications were not stopped for thePlease cite this article as: O. Domanski, et al., Cardiopulmonary exercise te
asymptomatic aortic stenosis, Int J Cardiol (2016), http://dx.doi.org/10.10examination. Patients were encouraged to exercise until exhaustion. Blood pressure was
measured every 2 min; continuous 12-lead electrocardiogram and saturation monitoring
(SpO2) were recorded. Breath-by-breath minute ventilation (VE), carbon dioxide produc-
tion (VCO2), their ratio (VE/VCO2), and oxygen consumption (VO2) were measured
using a pneumotach (Oxycon Pro, Viasys, France). Room temperature, barometric and hy-
grometric pressure were noted. A calibration of the pneumotach was realized before
every examusing a dosing syringe of 2 L, ﬁrst slowly then quickly. The respiratory exchange
ratio (RER)was deﬁned as VCO2/VO2. PeakVO2was expressed as absolute peak or normal-
ized peak (percent of predicted value derived fromWasserman formula) [21]. The VE/VCO2
slope was calculated by linear regression. The O2-pulse, an estimate of stroke volume, was
calculated as VO2/heart rate. Altered O2-pulse was deﬁned as b85% of predicted value or
b100% when patients were under beta blocker therapy (due to induced bradycardia
under treatment). LV stroke volume was calculated at peak exercise using Wasserman's
equation [21]. Abnormal test was deﬁned with the same criteria that exercise echocardiog-
raphy. Exercise was considered maximal when patients reached 85% of predicted
maximumheart rate, or when RER was ≥1.15. Functional capacity was considered reduced
when peak VO2 was b85% of predicted value. Cardiac limitation was deﬁned as a peak
VO2 b 85% associated with a low O2-pulse as previously described [22]. Pulmonary limita-
tionwas deﬁned as peak VO2 b 85% associatedwith ventilatory reserve b 20% or occurrence
of oxygen blood desaturation (SpO2 b 92%) during exercise. Muscular limitation was
diagnosed when functional capacity was reduced without cardiac or pulmonary
limitation. Venous blood sample was taken just before CPX for hemoglobin and NT-
proBNP measurements.2.4. Patients' follow-up
Patients were prospectively followed after the initial examination every 6 months.
Particular care was taken to obtain information for symptom onset, surgical aortic valve
replacement and death. The clinical management was determined independently by the
patient's personal physician.
Events were deﬁned as occurrence of cardiovascular death or need for aortic valve
replacement motivated by the development of symptoms or LV systolic dysfunction
(LVEF b 50%).2.5. Statistical analysis
Continuous variables with a Gaussian distribution are given as mean ± SD. Continu-
ous variableswith noGaussian distribution are given asmedian [25th to 75th] percentiles.
Categorical variables are given as the number (percentage) of patients with the respective
attribute. Bivariate comparisons were performed using the t-test for normally distributed
continuous variables or the Mann–Whitney U test for variables not normally distributed.
Bivariate comparisons of categorical variables were performed with the chi-square test.
Pearson's test was performed to evaluate potential correlations between peak VO2
and clinical, biological and echocardiographic parameters. Potential predictors for
peak VO2 with p-value b 0.05 on bivariate analysis were entered in a multivariate step-
wise linear regressionmodel using backward variable selection. Exercise echocardiographic
severity criteria were forced into themodel (exercise PHT N 60 mmHg, mean aortic gradi-
ent increase N 18 mm Hg, LV ejection fraction decrease N 3%) because of their clinical
relevance. Event rates were estimated using Kaplan–Meier method and compared using a
log-rank test. A value of p b 0.05 was considered statistically signiﬁcant. All analyses were
conducted using Medcalc Software Version 15.8 (MedCalc Software bvba, Ostend,
Belgium). Figures were drawn with GraphPad Prism v5.0.3. Results
3.1. Patient characteristics and supine exercise echocardiography
Patient characteristics are presented in Table 1. Fifty one patients
with asymptomatic aortic stenosis (LV aortic valve area 0.97 ±
0.24 cm2, Vmax 4.04 ± 0.74 m/s) and preserved ejection fraction
(LVEF ≥ 50%)were explored. Aortic stenosiswas secondary to a bicuspid
valve in 35 patients (69%), degenerative in 12 patients, rheumatic in 2
patients and due to congenital valve hypoplasia in 2 patients. Our
population was relatively young (54 ± 21 years) with a sex ratio of
nearly 1 and few co-morbidities. Most of the patients had normal
blood NT-proBNP level.
Supine exercise was performed to exhaustion in all patients without
any complex ventricular arrhythmia or criteria for myocardial ischemia.
Almost half of the patients displayed exercise echocardiographic criteria
of poor prognosis (Table 2): 4 patients (8%) developed exercise PHT,
10 (20%) presented an abnormal increase of mean trans-aortic gradient
(N18 mm Hg) and 10 (20%) revealed a decrease of LVEF at peak
exercise.sting is a better outcome predictor than exercise echocardiography in
16/j.ijcard.2016.10.070
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n = 51 n = 29 n = 22
Clinical
Age (years) 54 ± 21 51 ± 21 56 ± 21 0.42
Female gender, n (%) 24 (47%) 14 (48%) 10 (45%) 0.99
BMI (kg/m2) 26 ± 5 28 ± 5 25 ± 4 0.03
Body surface area (m2) 1.78 ± 0.21 1,83 ± 0,18 1,71 ± 0,24 0.06
Betablocker 14 (27%) 8 (28%) 6 (28%) 0.99
Risk factors
Smokers 9 (18%) 6 (21%) 3 (14%) 0.71
Diabetes mellitus 10 (20%) 10 (34%) 0 (0%) b0.01
Hypertension 20 (39%) 13 (45%) 7 (32%) 0.99
Dyslipidemia 14 (27%) 9 (31%) 5 (23%) 0.54
Known coronary disease 2 (4%) 1 (3%) 1 (5%) 1
Biologic
Hemoglobin (g/dL) 14.0 ± 1.6 14.3 ± 1.9 14.2 ± 1.2 0.77
NT-proBNP (ng/mL) 253 [62;224] 77 [33;163] 113 [83;327] 0.59
Echographic data at rest
Heart rate (beats/min) 75 ± 15 79 ± 15 70 ± 14 0.02
Systolic arterial
pressure (mm Hg)
140 ± 19 137 ± 16 143 ± 21 0.31
Bicuspid valve 35 (69%) 19 (66%) 16 (73%) 0.76
Left atrial area (cm2) 21 ± 5 22 ± 6 20 ± 4 0.15
E/E′ ratio 10 ± 6 11 ± 8 8 ± 4 0.11
LV end-diastolic
volume (mL)
96 ± 23 96 ± 22 96 ± 24 0.95
LV mass index (g/m2) 100 ± 26 106 ± 32 93 ± 14 0.27
LV ejection fraction (%) 66 ± 6 65 ± 7 67 ± 4 0.22
Global longitudinal
strain (%)
−19.6 ± 2.9 −19.2 ± 2.6 −20.0 ± 3.3 0.36
LV aortic valve area (cm2) 0.97 ± 0.24 0.98 ± 0.24 0.96 ± 0.25 0.71
LV aortic valve
area b 0,06 cm2/m2
34 (67%) 20 (69%) 14 (63%) 0.77
Aortic jet velocity (m/s) 4.04 ± 0.74 4.09 ± 0.81 3.99 ± 0.66 0.66
Aortic jet velocity N 4 m/s 25 (49%) 16 (55%) 9 (41%) 0.40
Aortic jet velocity N 5 m/s 4 (8%) 4 (14%) 0 (0%) 0.12
Mean transaortic pressure
gradient
40 ± 16 41 ± 16 40 ± 16 0.87
LV stroke volume (mL) 84 ± 16 84 ± 15 84 ± 17 0.91
ZVA (mm Hg/mL/m2) 3.69 ± 1.24 3.67 ± 1.31 3.67 ± 1.18 0.41
Transtricuspid pressure
gradient (mm Hg)
25 ± 8 27 ± 9 22 ± 5 0.03
TAPSE (mm) 22 ± 4 22 ± 5 23 ± 3 0.8
Data presented are number of patients (percent) or mean ± SD. p-Value b 0.05 was
considered signiﬁcant. BMI, Body Mass Index; LV, left ventricle; PV, predicted value;
TAPSE, tricuspid annular plane systolic excursion.
3O. Domanski et al. / International Journal of Cardiology xxx (2016) xxx–xxx3.2. Aerobic capacity in asymptomatic aortic stenosis
Peak VO2 was unexpectedly low for these asymptomatic middle-
aged patients (i.e. 21.9 ± 7.4 mL/kg/min or 83 ± 17% of predicted
value). Twenty nine patients (57%) had reduced aerobic capacity
deﬁned as peak VO2 b 85% of predicted value (Table 3). Most of
these patients (n = 20, 69%) displayed criteria for cardiac limitation
with (i) normal hemoglobin but low O2-pulse at peak exercise and
(ii) accordingly lower calculated LV stroke volume at peak exercise
than patients with peak VO2 ≥ 85% of predicted value (60 ± 25 vs
85 ± 28 mL, p = 0.01).
Of note, an abnormal decrease in systolic blood pressure was
observed in 3 patients, among which two had peak VO2 b 85% of
predicted value.
Compared to patientswith conserved aerobic capacity, patientswith
decreased peak VO2 (b85% of predicted value) were more often
overweight and diabetic, with higher heart rate and transtricuspid
pressure gradient at rest. AS severity did not differ between the2 groups
(aortic valve area: 0.98± 0.24 vs 0.96± 0.25 cm2, p=0.71; peak aortic
jet velocity: 4.09 ± 0.81 vs 3.99 ± 0.66 m/s, p = 0.66). Surprisingly,
there was no signiﬁcant difference between the two groups regarding
echocardiographic data at supine exercise, even for maximal workload
(94± 36 vs 101± 49W, p= 0.57). Exercise echocardiographic criteria
of poor prognosis were equally present in the two groups.
To better understand poor aerobic capacity in patients with asymp-
tomatic aortic stenosis, we further explored correlations of peak VO2
(mL/min/kg). In bivariate analysis, peak VO2 signiﬁcantly correlated
with numerous parameters, i.e. age, gender, weight status, history of
diabetes mellitus and hypertension, bicuspid valve, E/e′ ratio at rest
and peak exercise, LV aortic valve area at rest and peak exercise,
transtricuspid pressure gradient (Tables 4 and 5).
Yet, after multivariate adjustment, the only independent determi-
nants of peak VO2 were age, BMI and female gender (Table 6). Aortic
stenosis severity and exercise echocardiographic criteria of poor
prognosis (i.e. mean aortic valve gradient increase N 18 mm Hg, LVEF
decrease N 3%, or exercise PHT N 60 mm Hg) were not independently
associated with peak VO2 (Fig. 1; Table 5).
3.3. Predictors of outcome in asymptomatic aortic stenosis
Among our population of 51 patients, no patient died during the
21± 7month follow-up, 20 underwent aortic valve surgery. As expect-
ed, no event occurred before 9 months of follow-up since enrolled
patients were asymptomatic patients with normal LVEF.
Five patients underwent surgery for other reasons than symptoms
or onset of LV dysfunction: 1 for pregnancy desire, 1 for endocarditis,
3 for young age (the presence of symptoms being hard to evaluate
under 20 years old) and were therefore excluded from survival
statistics.
There was no difference in survival between patients having
exercise echocardiographic parameters of severity (i.e. exercise
PHT N 60 mm Hg, transaortic gradient increase N 18 mm Hg and/or
LVEF decrease N 3%) and the others (free event survival, 80 ± 11%
versus 70 ± 11% respectively, p = 0.38) (Fig. 2A). Conversely, patients
with conserved aerobic capacity (peak VO2 ≥ 85% of predicted value)
had a higher rate of event-free survival at 21 ± 7 months follow-up
(93± 6% vs 57± 11%, p= 0.036) (Fig. 2B). Peak VO2was thus a better
outcome predictor than exercise echocardiographic parameters of
severity in our asymptomatic AS patients. Peak VO2 ≥ 85% had a
negative predictive value of 97% to develop symptoms or LV dysfunction.
4. Discussion
We report here the ﬁrst prospective work comparing semi-supine
exercise echocardiography with cardio-pulmonary exercise test for
the close follow-up of a moderate to severe asymptomatic aorticPlease cite this article as: O. Domanski, et al., Cardiopulmonary exercise te
asymptomatic aortic stenosis, Int J Cardiol (2016), http://dx.doi.org/10.10stenosis population. Our main ﬁndings are that (i) a signiﬁcant propor-
tion of asymptomatic AS patients have low peak VO2 due to cardiac or-
igin, with low O2 pulse, (ii) peak VO2 was signiﬁcantly lower in
overweight patients, with history of diabetes, higher resting heart rate
and transtricuspid gradient at rest, (iii) peak VO2 did not correlate ei-
ther with resting parameters of AS severity, nor with exercise echocar-
diographic parameters of poor prognosis, and (iv) low peak VO2
predicted poor outcome in this population.4.1. CPX in asymptomatic AS patients
In fact, CPX splits the asymptomatic AS population in two groups
revealing false asymptomatic patients with low peak VO2 (b85% of
predicted value). Indeed, in ourwork, a signiﬁcant proportion of asymp-
tomatic patients (57%) had a low peak VO2. Recently, Dhoble et al. also
showed in a population of 151 moderate to severe AS patients that 54%
of them had an altered peak VO2 [13]. Interestingly, we ﬁrststing is a better outcome predictor than exercise echocardiography in
16/j.ijcard.2016.10.070
Table 2
Echocardiographic data at exercise.
Overall Peak VO2 b 85% PV Peak VO2 ≥ 85% PV p
n = 51 n = 29 n = 22
Echographic data at exercise
Systolic arterial pressure (mm Hg) 138 ± 27 155 ± 25 165 ± 24 0.19
Maximal heart rate (beats/min) 83 ± 12 142 ± 28 134 ± 26 0.3
Maximal heart rate (% theory) 83 ± 12 84 ± 12 83 ± 12 0.76
Peak workload (W) 96 ± 41 94 ± 36 101 ± 49 0.57
E/E′ ratio 10 ± 4 10 ± 5 9 ± 3 0.56
LV ejection fraction (%) 70 ± 7 70 ± 7 71 ± 6 0.53
Global strain 25 W (%) −21.3 ± 2.4 −21.6 ± 2.7 −21.2 ± 2.3 0.69
LV aortic valve area (cm2) 1.10 ± 0.38 1.12 ± 0.35 1.07 ± 0.43 0.66
Aortic jet velocity (m/s) 4.38 ± 0.76 4.45 ± 0.78 4.3 ± 0.78 0.54
Mean transaortic pressure gradient 49 ± 17 51 ± 18 47 ± 15 0.41
LV stroke volume (mL) 81 ± 26 76 ± 29 87 ± 20 0.15
Transtricuspid pressure gradient (mm Hg) 41 ± 11 41 ± 12 42 ± 10 0.81
TAPSE (mm) 25 ± 4 25 ± 3 25 ± 3 0.55
Exercise criteria of poor prognosis:
LV ejection fraction decrease N 3% 10 (20%) 5 (17%) 5 (23%) 0.73
Mean gradient increase N 18 mm Hg 10 (20%) 4 (14%) 6 (27%) 0.29
Exercise PHT N 60 mm Hg 4 (8%) 1 (3%) 3 (14%) 0.30
Data presented are number of patients (percent) or mean ± SD. p-Value b 0.05 was considered signiﬁcant.
LV, left ventricle; PHT, pulmonary hypertension; PV, predicted value; TAPSE, tricuspid annular plane systolic excursion.
4 O. Domanski et al. / International Journal of Cardiology xxx (2016) xxx–xxxdemonstrated that this alteration resulted mainly from cardiac limita-
tion since 69% of patients had also a low oxygen pulse in the absence
of anemia.
The only three independent determinants of poor aerobic capacity
(peak VO2 b 85% of predicted value) in our study were age, female
gender (as previously described) [23,24], and BMI. Peak VO2 is well
known to depend on age, gender and weight [21].
No marker of AS severity or LV function obtained at rest was able to
predict peak VO2 in our work. Accordingly, Dulgheru et al. did not ﬁnd
any signiﬁcant correlation between peakVO2and LVEF or parameters of
AS severity among 44 older (66± 13 years) asymptomatic moderate to
severe AS patients [23]. Interestingly, these authors showed that LV
longitudinal function of the basal myocardial segments is an indepen-
dent determinant of peak VO2, by contrast to global longitudinal strain.Table 3
Cardiopulmonary exercise test data.
Overall
n = 51
Cardiopulmonary exercise test data
VEMS (L) 2.64 ± 0.79
VEMS/CVF b 70% 1 (2%)
RER 1.16 ± 0.09
Systolic arterial pressure (mm Hg) 167 ± 24
Drop of systolic arterial pressure, n (%) 3 (6%)
Maximal heart rate (beats/min) 146 ± 31
Maximal heart rate (% PV) 87 ± 12
Peak workload (W) 114 ± 47
Peak VO2 (mL/kg/min) 21.9 ± 7.4
Peak VO2 (% PV) 83 ± 17
Maximal O2 pulse (mL/min) 10.7 ± 3.8
Maximal O2 pulse (% PV) 96 ± 23
O2 pulse ≥ 85% PV 29 (57%)
Wasserman stroke volume at exercise (mL) 72 ± 29
VE/VCO2 slope 31 ± 7




Data presented are number of patients (percent) or mean ± SD. p-Value b 0.05 was considere
PV, predicted value; RER, respiratory exchange ratio; VE, ventilation; VCO2, carbon dioxide ou
Please cite this article as: O. Domanski, et al., Cardiopulmonary exercise te
asymptomatic aortic stenosis, Int J Cardiol (2016), http://dx.doi.org/10.10Wedid not speciﬁcally explore basal longitudinal strain, but we showed
as Dulgheru et al. that LVEF is probably not the best index to assess LV
systolic performance in AS although it is the only LV function parameter
used to recommend AVR in asymptomatic patients with severe AS.
In another study, Steadman et al. found that peak VO2was not asso-
ciated with late gadolinium enhancement, or myocardial performance
reserve using cardiacmagnetic resonance, among 46 severe AS patients.
Again no link between echocardiographic measurements of AS severity
and peak VO2 was established [25].
Interestingly, limitation in peripheral oxygen transport and utiliza-
tion have been observed in patients with preserved and altered heart
failure because of reduced capillary density in skeletal muscle, impaired
sympatholysis, decreasedmitochondrial biogenesis and selective loss of
type 1 oxidative muscle ﬁbers [26]. Besides, exaggerated ventilatoryPeak VO2 b 85% PV Peak VO2 ≥ 85% PV p
n = 29 n = 22
2.60 ± 0.82 2.69 ± 0.79 0.39
1 (3%) 0 (0%) 1
1.18 ± 0.1 1.14 ± 0.07 0.28
171 ± 25 161 ± 23 0.25
1 (3%) 2 (9%) 0.57
150 ± 33 164 ± 22 0.39
88 ± 14 86 ± 9 0.58
106 ± 40 124 ± 54 0.18
19 ± 6.1 25.7 ± 7.3 b0.01
71 ± 8 99 ± 13 b0.01
9.5 ± 3 12.1 ± 4.3 0.02
82 ± 18 114 ± 18 b0.01
8 (28%) 21 (95%) b0.01
60 ± 25 85 ± 28 0.01
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Female gender 0.12 0.01
BMI (kg/m2) 0.26 b0.01
Diabetes mellitus 0.18 b0.01
Hypertension 0.27 b0.01
Biologic
Hemoglobin (g/dL) 0.12 0.03
Log NT-proBNP (ng/mL) 0.13 0.03
Echographic data at rest
Bicuspid valve 0.14 b0.01
Left atrial area (cm2) 0.1 0.02
E/e′ ratio 0.17 b0.01
LV end-diastolic volume (mL) 0.01 0.98
LV ejection fraction (%) 0.01 0.82
Global strain (%) 0.03 0.26
LV aortic valve area (cm2) 0.09 0.03
Aortic jet velocity (m/s) 0.04 0.18
Aortic jet velocity N 4 m/s 0.01 0.91
Aortic jet velocity N 5 m/s 0.04 0.17
Mean transaortic pressure gradient 0.02 0.27
LV stroke volume (mL) 0.01 0.75
Transtricuspid pressure gradient (mm Hg) 0.15 b0.01
TAPSE (mm) 0.04 0.17
p-Value b 0.05 was considered signiﬁcant.
BMI, BodyMass Index; LV, left ventricle; TAPSE, tricuspid annular plane systolic excursion.
Table 6
Multiple regression analysis for prediction of peak VO2 in the whole population.
Coefﬁcient Standard error p value
Age (per year) −0.18 0.03 b0.001
BMI (kg/m2) −0.36 0.16 0.03
Female gender −4.9 1.3 b0.001
Potential predictors for peak VO2 with p-value b 0.05 on bivariate analysis (age, BMI,
hemoglobin, log NT-proBNP, left atrial area, E/E′ moy, LV aortic valve area, transtricuspid
pressure gradient, gender female, diabetes mellitus, hypertension, bicuspid valve) were
added to the multivariate stepwise linear regression model using backward variable
selection. Relevant variables were forced into the model (exercise PHT N 60 mm Hg,
mean aortic gradient increase N 18 mm Hg, LV ejection fraction decrease N 3%) because
of their clinical relevance.
BMI, Body Mass Index.
5O. Domanski et al. / International Journal of Cardiology xxx (2016) xxx–xxxresponses to exercise are present in HF as a result of overactivity of
ergoreceptors which are intramuscular afferents sensitive to products
of skeletal muscle work [27]. All these conditions leading to peripheral
deconditioning can explain the differences in exercise tolerance for
similar level of AS severity. Peak VO2 provides perspective on the
overall physiology of the body during maximal exercise but also during
physical stress such as acute heart failure, systemic infection, and surgi-
cal stress. It is thus not surprising that peak VO2 is strongly linked to
clinical outcome in our population as in other cardiovascular and non-
cardiovascular diseases [28]. Further studies should be performed to
elucidate the exact role and determinants of peripheral (mal)adaptive
mechanisms in this speciﬁc population.
We provide the ﬁrst comprehensive exploration of AS patients with
supine exercise echocardiography together with CPX. Dalsgaard et al.
already demonstrated that peak exercise E/e′ ratio was poorly correlat-
ed with invasive measurements of pulmonary capillary wedge pressure
at rest in severe AS [29]. Accordingly, peak E/e′ ratio was notTable 5
Relationship between peak VO2 and exercise echocardiographic parameters.
Variables r2 p
Echocardiographic data at exercise
E/e′ ratio 0.16 0.01
LV ejection fraction (%) 0.01 0.52
Global strain 25 W (%) 0.05 0.37
LV aortic valve area (cm2) 0.09 0.03
Aortic jet velocity (m/s) 0.04 0.18
Mean transaortic pressure gradient 0.06 0.09
LV stroke volume (mL) 0.05 0.14
Transtricuspid pressure gradient (mm Hg) 0.01 0.75
TAPSE (mm) b0.01 0.7
Exercise criteria of poor prognosis:
LV ejection fraction decrease N 3% 0.01 0.87
Mean gradient increase N 18 mm Hg 0.01 0.60
Exercise PHT N 60 mm Hg b0.01 0.52
p-Value b 0.05 was considered signiﬁcant.
LV, left ventricle; PHT, pulmonary hypertension; TAPSE, tricuspid annular plane systolic
excursion.
Fig. 1. Peak VO2 in patients with aortic stenosis grouped according to exercise
echocardiographic severity criteria. Data are presented as mean ± Standard
Deviation, p-value was calculated using a Mann–Whitney U test. A. Patients with
and without exercise pulmonary hypertension; B. patients with and without mean
gradient increase N 18 mm Hg; C. patients with and without LVEF decrease. EPHT,
exercise pulmonary hypertension; LVEF, left ventricle ejection fraction; MGI, mean
gradient increase.
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Fig. 2. Clinical outcome in asymptomatic patients with aortic stenosis. Kaplan–Meier
curves according to: a. ≥1 exercise criteria of bad prognosis (i.e. exercise
PHT N 60 mm Hg, mean transaortic gradient increase N 18 mm Hg and/or LVEF
decrease N 3%) (solid line) or no exercise criterion (dotted line) and b. peak
VO2 ≥ 85% of predicted value (solid line) or peak VO2 b 85% of predicted value
(dotted line) at 28 months or 854 days follow-up. Events were death or cardiac
surgery for symptom onset or alteration in LVEF. Note the signiﬁcant excess event
rate in patients with peak VO2 b 85% of predicted value. p-Value by log-rank test.
6 O. Domanski et al. / International Journal of Cardiology xxx (2016) xxx–xxxindependently correlated with peak VO2 in our population. Surprising-
ly, we did not ﬁnd any correlation between classical exercise echo-
cardiographic parameters of asymptomatic AS severity (i.e.
exercise PHT N 60 mm Hg, increase of mean transaortic
gradient N 18 mm Hg and decrease of LVEF N 3%) with peak VO2, sug-
gesting that this parameter reﬂects more a general body adaptation
and is thus well correlated with symptoms and outcomes.
4.2. Risk stratiﬁcation in asymptomatic AS
We were able to demonstrate that altered peak VO2 (b85% of
predicted value) predicted poor outcome, with a lower event-free sur-
vival than preserved peak VO2 (≥85% of predicted value). In patients
with severe LV dysfunction, peak VO2 is a well-proven determinant of
survival, even in the setting of beta-blockade [30,31], so that CPX has a
key role for heart transplantation selection in this population. Few
recent studies highlighted its potential role in surgical selection of
asymptomatic AS patients [12,13,23,24,32]. Levy et al. already proved
in a small population of 43 asymptomatic AS patients that peak
VO2 ≤ 14 mL/kg/min was associated with the occurrence of European
Society of Cardiology guideline surgical class I triggers [12].
In the past few years, increase in mean transaortic pressure
gradient ≥ 18 to 20 mm Hg [9,11], absence of LV contractile reserve
[33], and exercise pulmonary hypertension N 60 mm Hg [10] detected
by supine exercise echocardiography were shown to have prognostic
signiﬁcance. Surprisingly, we were not able demonstrate any impact
on survival of these criteria. Nevertheless our population was quite dif-
ferent, particularly younger, than those reported in these other studies,
i.e. 54 ± 21 years old to be compared with 71 ± 9 years old in
Lancellotti's study and 64 ± 15 years old in Marechaux's work. Thus
our population had few cardiovascular risk factors, a high incidence of
bicuspid valve (69%), and a low rate of coronary heart disease. ThisPlease cite this article as: O. Domanski, et al., Cardiopulmonary exercise te
asymptomatic aortic stenosis, Int J Cardiol (2016), http://dx.doi.org/10.10was translated into the low cardiac event-rate (39% at 21 ± 7 months)
we observed in comparison to others.
4.3. Clinical implications
CPX may have a pivotal role in screening false asymptomatic AS
patients in the future, as it objectively identiﬁes low aerobic capacity
in almost two thirds of patients, and thus patients with bad prognosis,
who may be at higher risk of developing symptoms or LV dysfunction.
Interestingly, normal aerobic capacity, i.e. VO2 peak ≥ 85% of predicted
value, has an excellent negative predictive value of 97%,when abnormal
exercise testing guided by symptoms has a reported negative predictive
value of 79 to 87% [34,35]. CPX may thus be a very helpful tool within
a watchful waiting strategy, and cannot be replaced by exercise
echocardiography.
5. Limitations
Coronary arteriography was not realized in the whole population,
so we cannot exclude that cardiac limitationwas linked to coronary dis-
ease in some cases. However, our populationwas relatively young, with
a largemajority of bicuspid valves, and a low cardiovascular risk proﬁle.
Our results are limited to 51 patients. However, all patients
were carefully and prospectively underwent the three comprehensive
exams (CPX, echocardiography at rest and exercise, biology) at the
same period.
Aortic stenosis severity was evaluated in multiple transducer posi-
tions at rest as recommended, but only in the 5-chamber view during
exercise because of patient's position, as previously reported by others
[8]. This is an intrinsic limitation of aortic stenosis exploration during
supine exercise which may result in underestimation of peak velocity.
Yet the transaortic gradient increase was calculated with transaortic
gradients obtained in 5 chamber views at rest and peak exercise.
6. Conclusion
In severe asymptomatic aortic stenosis patients, CPX objectively
detects a high proportion of false “asymptomatic” patients secondary
to cardiac limitation. Decreased aerobic capacity cannot be predicted
by supine exercise echocardiography. Conserved aerobic capacity
(peak VO2 ≥ 85% of predicted value) identiﬁes a low risk population,
for which watchful waiting strategy appears relevant. Conversely, false
asymptomatic patients (deﬁned by peak VO2 b 85% of predicted
value) are faced with signiﬁcant cardiac events and should be referred
to the surgeon.
7. Perspectives
As elective surgery cannot be recommended in every patient with
asymptomatic severe aortic stenosis, reliable risk estimation and appro-
priate aortic valve replacement indication and timing are important
clinical challenges. Cardiopulmonary exercise testingdetects a high pro-
portion of false asymptomatic aortic stenosis patients with low peak
VO2associatedwith poor outcome that is not predicted by resting or su-
pine exercise echocardiographic parameters of aortic stenosis severity.
Since peak VO2 ≥ 85% of predicted value revealed to have an excellent
negative predictive value, assessment of aerobic capacity using peak
oxygen consumption should be part of current approaches to guide
physician's decision making within a “watchful waiting” strategy.
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